Skip to main content
SpringerLink
Log in

Primary breast lymphoma

  • Chapter
Management of Rare Adult Tumours

  • 1025 Accesses

Abstract

The term “primary breast lymphoma” (PBL) is used to define malignant lymphoma primarily occurring in the breast in the absence of other previously detected lymphoma localizations. The first definition was proposed by Wiseman and Liao in 1972 [49]. The clinical pathological criteria for the definition of PBL include: “the clinical site of presentation is the breast, the absence of disseminated lymphoma or preceding extra-mammary lymphoma at the time of diagnosis, adequate pathological specimen evaluation, histological evidence of a close association between the mammary tissue and the lymphomatous infiltrate, and presence of homolateral axillary lymph nodes that may be involved if they develop simultaneously with the primary breast tumor”.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abbondanzo SL, Seidman JD, Lefkowitz M et al. (1996) Primary diffuse large B-cell lymphoma of the breast. A clinicopathologic study of 31 cases. Pathol Res Pract 192(1): 37–43

    CAS  PubMed  Google Scholar 

  2. Arber DA, Simpson JF, Weiss LM et al. (1994) Non-Hodgkin’s lymphoma involving the breast. Am J Surg Pathol 18(3): 288–95

    Article  CAS  PubMed  Google Scholar 

  3. Avilés A, Castañeda C, Neri N et al. (2007) Rituximab and dose dense chemotherapy in primary breast lymphoma. Haematologica 92(08): 1147–8.

    Article  PubMed  Google Scholar 

  4. Avilés A, Delgado S, Nambo MJ et al. (2005) Primary Breast Lymphoma: Results of a Controlled Clinical Trial. Oncology 69: 256–60

    Article  PubMed  Google Scholar 

  5. Bai M, Agnantis NJ, Skyrlas A et al. (2003) Increased Expression of the bcl6 and CD 10 Proteins Is Associated with Increased Apoptosis and Proliferation in Diffuse Large B-Cell Lymphomas. Mod Pathol 16: 471–80

    Article  CAS  PubMed  Google Scholar 

  6. Baker R, Slayden G, Jennings W et al. (2005) Multifocal primary breast lymphoma. South Med J 98: 1045–8

    Article  PubMed  Google Scholar 

  7. Bakheet SM, Bakheet R, Ezzat A et al. (2001) F-18 FDG Positron Emission Tomography in Primary Breast Non-Hodgkin’s Lymphoma. Clin Nucl Med 26: 299–301

    Article  CAS  PubMed  Google Scholar 

  8. Barrans SL, Carter I, Owen RG et al. (2002) Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lypmphoma. Blood 99: 1136–43

    Article  CAS  PubMed  Google Scholar 

  9. Barrans SL, O’Connor SJ, Evans PA et al. (2002) Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse B-cell lymphoma. Br J Haematol 117: 322–32

    Article  CAS  PubMed  Google Scholar 

  10. Bobrow LG, Richards MA, Happerfield LC et al. (1993) Breast lymphomas: a clinicopathologic review. Hum Pathol 24(3): 274–8

    Article  CAS  PubMed  Google Scholar 

  11. Brogi E, Harris NL (1999) Lymphomas of the breast: pathology and clinical behavior. Semin Oncol 26(3): 357–64

    CAS  PubMed  Google Scholar 

  12. Brustein S, Kimmel M, Lieberman PH et al. (1987) Malignant Lymphoma of the Breast. A study of 53 patients. Ann. Surg vol 205(2): 144–50

    Article  CAS  PubMed  Google Scholar 

  13. Carbone PP, Kaplan HS, Musshoff K et al. (1971) Report of the Committee on Hodgkin’s disease staging classification. Cancer Res 31: 1860–1

    CAS  PubMed  Google Scholar 

  14. Coiffier B, Lepage E, Briere J et al. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: 235–42

    Article  CAS  PubMed  Google Scholar 

  15. Dao AH, Adkins RB Jr, Glick AD et al. (1992) Malignant lymphoma of the breast: a review of 13 cases. Am Surg 58(12): 792–6

    CAS  PubMed  Google Scholar 

  16. Delbeke D (1999) Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med 40: 591

    CAS  PubMed  Google Scholar 

  17. Dixon JM, Lumsden AB, Krajewski A et al. (1987) Primary lymphoma of the breast. Br J Surg 74: 214–6

    Article  CAS  PubMed  Google Scholar 

  18. Domchek SM, Hecht JL, Fleming MD et al. (2002) Lymphomas of the breast. Primary and Secondary Involvement. Cancer 94: 6–13

    Article  PubMed  Google Scholar 

  19. Duncan VE, Reddy VVB, Jhala NC et al. (2006) Non-Hodgkin’s lymphoma of the breast: a review of 18 primary and secondary cases. Annals of Diagnostic Pathology 10:144–8

    Article  PubMed  Google Scholar 

  20. Farinha P, Saudade A, Cabecadas J et al. (2000) High frequency of MALT lymphoma in a series of 14 cases of primary breast lymphoma. Appl Immunol Mol Morpho 10: 115–26

    Article  Google Scholar 

  21. Fruchart C, Denoux Y, Chasle J et al. (2005) High grade primary breast lymphoma: is it a different clinical entity? Breast Cancer Research and Treatment 93: 191–8

    Article  PubMed  Google Scholar 

  22. Ganjoo K, Advani R, Mariappan MR et al. (2007) Non-Hodgkin Lymphoma of the Breast. Cancer 110: 25–30

    Article  PubMed  Google Scholar 

  23. Giardini R, Piccolo C, Rilke F et al. (1992) Primary non-Hodgkin’s lymphomas of the female breast. Cancer 69(3): 725–35

    Article  CAS  PubMed  Google Scholar 

  24. Gupta D, Shindham V, Zemba-Palko V, Keshgegian A (2000) Primary bilateral mucosa-associated lymphoid tissue lymphoma of the breast with atypical ductal hyperplasia and localized amyloidosis. A case report and review of the literature. Arch Pathol lab Med 124: 1233–6

    CAS  PubMed  Google Scholar 

  25. Ha CS, Dubey P, Goyal LK et al. (1998) Localized Primary Non-Hodgkin Lymphoma of the Breast. Am J Clin Oncol 21(4): 376–80

    Article  CAS  PubMed  Google Scholar 

  26. Horning SJ, Weller E, Kim K et al. (2004) Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin’s lymphoma: Eastern Cooperative Oncology group Study 1484. J Clin Oncol 22: 3032–8

    Article  CAS  PubMed  Google Scholar 

  27. Hugh JC, Jackson FI, Hanson J et al. (1990) Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer 66: 2602–11

    Article  CAS  PubMed  Google Scholar 

  28. The International Non-Hodgkin’s lymphoma Prognostic Factors Project (1993) A predictive Model for aggressive Non-Hodgkin’s Lymphoma.N Engl J Med 329: 987–94

    Article  Google Scholar 

  29. Jeanneret Sozzi W, Taghian A, Epelbaum R et al. (2008) Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study. BMC Cancer 8: 86

    Article  PubMed  Google Scholar 

  30. Jennings WC, Baker RS, Murray SS et al. (2007) Primary Breast Lymphoma. The Role of Mastectomy and the Importance of Lymph Node Status. Ann Surg 245: 784–9

    Article  PubMed  Google Scholar 

  31. Kambouchner M, Godmer P, Guillevin L et al. (2003) Low grade marginal zone B cell lymphoma of the breast associated with localized amyloidosis and corpora amylacea in a woman with long standing primary Sjogren’s syndrome. J Clin Pathol 56: 74–7

    Article  CAS  PubMed  Google Scholar 

  32. Kuper-Hommel MJJ, Snijder S, Janssen-Heijnen MLG et al. (2003) Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews. Ann Hematol 82: 397–404

    Article  CAS  PubMed  Google Scholar 

  33. Lavomec J, Jancar J (1987) Primary malignant lymphoma of the breast: lymphoma of the mucosa-associated lymphoid tissue. Cancer 60: 3033–41

    Article  Google Scholar 

  34. Liberman L, Giess CS, Dershaw DD et al. (1994) Non-Hodgkin Lymphoma of the Breast: Imaging Characteristics and Correlation with Histopathologic Findings. Radiology 192: 157–60

    CAS  PubMed  Google Scholar 

  35. Lin Y, Guo XM, Shen KW et al. (2006) Primary breast lymphoma: Long-term treatment outcome and prognosis. Leukemia & Lymphoma 47(10): 2102–9

    Article  Google Scholar 

  36. Liu MT, Hsieh CY, Wang AY et al. (2005) Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases. Ann Saudi Med 25(4): 288–93

    PubMed  Google Scholar 

  37. Lyons JA, Myles J, Pohlman B et al. (2000) Treatment and Prognosis of Primary Breast Lymphoma: A Review of 13 Cases. Am J Clin Oncol 23(4): 334–6.

    Article  CAS  PubMed  Google Scholar 

  38. Lyou CY, Yang SK, Choe DH et al. (2007) Mammographic and sonographic findings of primary breast lymphoma. Clinical Imaging 31: 234–8

    Article  PubMed  Google Scholar 

  39. Mattia AR, Ferry JA, Harris NL et al. (1993) Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol 17(6): 574–87

    Article  CAS  PubMed  Google Scholar 

  40. Miller T, Unger J, Spier C et al. (2004) Effect of adding rituximab to three cycles of CHOP plus involved field radiotherapy for limited stage aggressive diffuse large B-cell lymphoma (SWOG-0014) Blood 104: 48a–9a

    Google Scholar 

  41. Miller TP, LeBlanc M, Spier C et al. (2001) CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hogkin’s lymphoma: update of the Southwest Oncology Group (SWOG) randomized trial. Blood 98: 72A

    Article  Google Scholar 

  42. Pfreundschuh M., Trumper L, Osterborg A et al. (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large B-cell lymphoma: a randomized controlled trial by the Mab Thera International Trial (MinT) Group. Lancet Oncol. 7: 379–91

    Article  CAS  PubMed  Google Scholar 

  43. Ribrag V, Bibeau F, El Weshi A et al. (2001) Primary breast lymphoma: a report of 20 cases. British Journal of Haematology 115: 253–6

    Article  CAS  PubMed  Google Scholar 

  44. Ryan G, Martinelli G, Kuper-Hommel M et al. (2008) Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Group. Annals of Oncology 19: 233–41

    Article  CAS  PubMed  Google Scholar 

  45. Sabaté JM, Gómez A, Torrubia S et al. (2002) Lymphoma of the Breast: Clinical and Radiologic Features With Pathologic Correlation in 28 Patients. The Breast Journal 8(5): 294–304

    Article  PubMed  Google Scholar 

  46. Shouton JT, Weese JL, Carbone P et al (1981) Lymphoma of the breast. Ann Surg 194(69): 749–53

    Article  Google Scholar 

  47. Topalovski M, Crisan D, Mattson JC et al. (1999) Lymphoma of the Breast. A Clinicopathologic Study of Primary and Secondary Cases. Arch Pathol Lab Med 123: 1208–18

    CAS  PubMed  Google Scholar 

  48. Vignot S, Ledoussal V, Nodiot P et al (2005) Non-Hodgkin’s Lymphoma of the Breast: a Report of 19 Cases and Review of the Literature. Clin Lymphoma 6(1): 37–42

    Article  PubMed  Google Scholar 

  49. Wiseman C, Liao KT (1972) Primary lymphoma of the breast. Cancer 29(6) 1705–12

    Article  CAS  PubMed  Google Scholar 

  50. Wong WW, Schild SE, Halyard MY et al. (2002) Primary Non-Hodgkin Lymphoma of the Breast: The Mayo Clinic Experience. Journal of Surgical Oncology 80: 19–25

    Article  PubMed  Google Scholar 

  51. Yoshida S, Nakamura N, Sasaki Y et al. (2005) Primary breast diffuse large B-cell lymphoma shows a non-germinal B-cell phenotype. Modern Pathology 18: 398–405

    Article  CAS  PubMed  Google Scholar 

  52. Young SD, Imrie K, Gospodarowicz M et al. (1999) Primary lymphoma of the breast: a 30 year retrospective analysis of the Toronto experience. Proc ASCO 18:41a.

    Google Scholar 

  53. Zack RJ, Trevisan SG, Gupta M et al. (2001) Primary breast lymphoma originating in a benign intramammary lymph node. Am J Roentgenol 177: 177–8

    CAS  Google Scholar 

Download references

Authors
  1. W. Jeanneret Sozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R.-O. Mirimanoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital Henri-Mondor, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94000, Créteil Cedex, France

    Yazid Belkacémi MD PhD (Professor Radiation Oncology, Deputy Head of the Department of Radiation Oncology) (Professor Radiation Oncology, Deputy Head of the Department of Radiation Oncology)

  2. Centre hospitalier universitaire Vaudoir, Rue du Bugnon, CH-1011, Lausanne, Switzerland

    René-Olivier Mirimanoff MD (Professeur Radiation Oncology, Head of the Department of Radiation Oncology) & Mahmut Ozsahin MD PhD (Associate Professor in the Department of Radiation Oncology) (Professeur Radiation Oncology, Head of the Department of Radiation Oncology) &  (Associate Professor in the Department of Radiation Oncology)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Jeanneret Sozzi, W., Mirimanoff, RO. (2009). Primary breast lymphoma. In: Belkacémi, Y., Mirimanoff, RO., Ozsahin, M. (eds) Management of Rare Adult Tumours. Springer, Paris. https://doi.org/10.1007/978-2-287-92246-6_40

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-92246-6_40

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-92245-9

  • Online ISBN: 978-2-287-92246-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation